Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakae, T. Articles by Yoneyama, H. Search for Related Content PubMed PubMed Citation Articles by Nakae, T. Articles by Yoneyama, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1999, p. 1301-1303, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Resistance to -Lactam Antibiotics in Pseudomonas aeruginosa Due to Interplay between the MexAB-OprM Efflux Pump and -Lactamase

Taiji Nakae,^* Akira Nakajima, Toshihisa Ono, Kohjiro Saito, and Hiroshi Yoneyama

Department of Molecular Life Science, Tokai University School of Medicine, Isehara 259-1193, Japan

Received 7 December 1998/Returned for modification 8 February 1999/Accepted 3 March 1999

	ABSTRACT

Top Abstract Text References

We evaluated the roles of the MexAB-OprM efflux pump and -lactamase in -lactam resistance in Pseudomonas aeruginosa by constructing OprM-deficient, OprM basal level, and OprM fully expressed mutants from -lactamase-negative, -inducible, and -overexpressed strains. We conclude that, with the notable exception of imipenem, the MexAB-OprM pump contributes significantly to -lactam resistance in both -lactamase-negative and -lactamase-inducible strains, while the contribution of the MexAB-OprM efflux system is negligible in strains with overexpressed -lactamase. Overexpression of the efflux pump alone contributes to the high level of -lactam resistance in the absence of -lactamase.

	TEXT

Top Abstract Text References

A major problem in Pseudomonas aeruginosa infection is that this organism exhibits natural and acquired resistance to many structurally and functionally diverse antibiotics. The multiple antibiotic resistance of this organism is mainly caused by low outer membrane permeability (11) and the expression of efflux pumps. Three efflux pumps have been documented (4, 5, 8, 14, 15) so far, namely the MexAB-OprM (10, 13), the MexCD-OprJ (12), and the MexEF-OprN (6) pumps. In the wild-type strain only the MexAB-OprM pump is expressed and the others are silent (4, 5, 10, 13). The nalB mutant overexpresses the MexAB-OprM pump (10, 13), rendering the bacterium more resistant than the wild-type strain to certain antibiotics (15). P. aeruginosa also expresses a chromosomally encoded -lactamase in the presence of an appropriate inducer and shows elevated resistance to -lactam antibiotics (2, 3). An earlier study predicted a possible interplay between membrane permeability and -lactamase in -lactam resistance in P. aeruginosa (7). Thus, it is important to ask which factor contributes most to resistance under various conditions. We addressed this issue by constructing a series of mutants producing different levels of the MexAB-OprM efflux pump and of -lactamase.

Table 1 lists the strains used, their relevant properties, and -lactamase activities. The strains PAO1, PAO4096, and TNP001 produce inducible, undetectable, and fully expressed -lactamase, respectively (2, 17). We mutagenized the oprM gene by inserting a Tet^r cassette as reported earlier (18). Manipulation of DNA has been described earlier (16). We confirmed the Tet^r marker insertion by amplification of the chromosomal oprM by PCR as described by Ausubel et al. (1) by using the primers 5'-CAGTTGCAGCTGACCAAGG and 5'-TCGCTGGCCTTGACCAGATCG (data not shown). We confirmed by the Western blotting method with an anti-OprM antibody (18) that the mutants carrying the Tet^r insertion in oprM showed no detectable OprM protein (data not shown).

View this table: [in this window] [in a new window]   TABLE 1.   Bacterial strains, relevant properties, and -lactamase activitiesa

We evaluated the role of the efflux pump without -lactamase by constructing OprM-deficient (OprM), OprM-constitutive (OprM⁺), and OprM-overexpressed (OprM⁺⁺⁺) mutants from a -lactamase-negative strain (Bla) which produces less than 0.9 × 10³ U of -lactamase (Table 1). The -lactam MICs for the Bla OprM⁺⁺⁺ derivative (TNP026) were 8 to 250 times higher than those for the Bla OprM strain (TNP027). These increases in MICs are attributable to the nalB mutation, notably overexpression of the MexAB-OprM pump. This new finding clearly shows that overexpression of the efflux pump alone confers high -lactam resistance without -lactamase. The -lactam MICs for the Bla OprM⁺ strain (PAO4096) were 2 to 64 times higher than those for the Bla OprM mutant (TNP027) except for meropenem. The higher MICs for PAO4096 than for TNP027 reflect the fraction that the basal level of the MexAB-OprM efflux pump contributes to the intrinsic -lactam resistance. This result is consistent with recently reported conclusions (9).

Experiments using the strains with fully expressed -lactamase (Bla^c OprM⁺, TNP001), an OprM derivative (TNP029), and an OprM⁺⁺⁺ derivative (TNP028) showed entirely different MIC profiles. First of all, the -lactam MICs for the Bla^c OprM strain (TNP029) were 64 to 2,000 times higher than those for the Bla OprM mutant (TNP027). This large difference in MICs appears to be due solely to the contribution of the fully expressed -lactamase (Table 2). The contributions of wild-type and elevated levels of MexAB-OprM expression in the TNP001 strain to the MICs of these -lactams were nearly masked by high -lactamase production, since the MICs of these antibiotics for the OprM⁺⁺⁺ derivative, TNP028, were only one to four times higher than those for TNP029. Based on these new findings, we conclude that in the -lactamase fully expressed strain, the -lactamase predominates in causing -lactam resistance and the role of the efflux pump is secondary.

View this table: [in this window] [in a new window]   TABLE 2.   MICs of antibiotics for strains with different levels of OprM expression and -lactamase productiona

In the next experiment, we designed an experiment taking a wild-type laboratory strain (PAO1) and constructing OprM (TNP025) and nalB (TNP024) mutants. The -lactamase activities of these strains in the presence and absence of the inducer were 0.59 to 0.67 U and 2.6 × 10³ to 2.8 × 10³ U, respectively (Table 1). The -lactam MICs for the wild-type strain, PAO1, were 0.39 to 25 µg/ml, and these values were unexpectedly only one to four times higher than the MICs of these antibiotics for the Bla counterpart (PAO4096). These results clearly indicate that the contribution of -lactamase to the MICs of these -lactams was marginal. This is probably due to poor -lactamase inducibility of the -lactams used, since the MICs of these antibiotics for the Bla^c strain (TNP001) were very high (Table 2).

To determine the role of the efflux pump in -lactam resistance, we compared the MICs of antibiotics for the Blaⁱ OprM⁺ (PAO1) and the Blaⁱ OprM (TNP025) strains. The -lactams MICs for PAO1 were 2 to 64 times higher than those for TNP025, indicating that the low-level expression of the efflux pump mainly contributes to the intrinsic resistance. This result is consistent with that of a recent report (9). In addition, the MICs of these antibiotics for the Blaⁱ OprM⁺⁺⁺ strain were 8- to 256-fold higher than those for the Blaⁱ OprM strain (TNP025). These results showed that the efflux pump alone can confer very high -lactam resistance with a negligible contribution of -lactamase. To ascertain the contribution of inducible -lactamase to -lactam resistance in the MexAB-OprM-overexpressed environment, we compared the MICs of -lactams for TNP024 and TNP026 and found that the MICs for TNP024 were only one to two times higher than those for TNP026, indicating again that the contribution of inducible -lactamase was small compared with that of the efflux pump under these conditions. After this paper was submitted for publication, Masuda et al. reported on the interplay between -lactamase and the efflux pump (9). Our results concur in part with theirs and add additional results.

	ACKNOWLEDGMENTS

This study was supported by grants from the Ministry of Education, the Ministry of Health and Welfare, the Japan Society of Promotion of Science, and the Tokai University School of Medicine.

	FOOTNOTES

^* Corresponding author. Mailing address: Department of Molecular Life Science, Tokai University School of Medicine, Isehara 259-1193, Japan. Phone: 81-465-93-5436. Fax: 81-463-93-5437. E-mail: nakae{at}is.icc.u-tokai.ac.jp.

	REFERENCES

Top Abstract Text References

1.	Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1995. Current protocols in molecular biology. Greene and Wiley Interscience, New York, N.Y.
2.	Bryan, L. E., S. Kwan, and J. A. Godfrey. 1984. Resistance of Pseudomonas aeruginosa mutants with altered control of chromosomal -lactamase to piperacillin, ceftazidime, and cefsulodin. Antimicrob. Agents Chemother. 25:382-384[Abstract/Free Full Text].
3.	Bryan, L. E. 1979. Resistance to antimicrobial agents: the general nature of the problem and the basis of resistance, p. 219-270. In R. G. Dogget (ed.), Pseudomonas aeruginosa. Clinical manifestation of infection and current therapy. Academic Press, New York, N.Y.
4.	Fukuda, H., M. Hosaka, K. Hirai, and S. Iyobe. 1990. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO. Antimicrob. Agents Chemother. 34:1757-1761[Abstract/Free Full Text].
5.	Hirai, K., S. Suzue, T. Irikura, S. Iyobe, and S. Mitsuhashi. 1987. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 31:582-586[Abstract/Free Full Text].
6.	Köhler, T., M. Michéa-Hamzehpour, V. Henze, N. Gotoh, L. K. Curty, and J.-C. Pechére. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354[Medline].
7.	Livermore, D. M., and K. W. M. Davy. 1991. Invalidity for Pseudomonas aeruginosa of an accepted model of bacterial permeability to -lactam antibiotics. Antimicrob. Agents Chemother. 35:916-921[Abstract/Free Full Text].
8.	Lei, Y., K. Sato, and T. Nakae. 1991. Ofloxacin-resistant Pseudomonas aeruginosa mutants with elevated drug extrusion across the inner membrane. Biochem. Biophys. Res. Commun. 178:1043-1048[Medline].
9.	Masuda, N., N. Gotoh, C. Ishii, E. Sakagawa, and T. Nishino. 1999. Interplay between chromosomal -lactamase and the MexAB-OprM efflux system in intrinsic resistance to -lactams in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:400-402[Abstract/Free Full Text].
10.	Morshed, S. R., Y. Lei, H. Yoneyama, and T. Nakae. 1995. Expression of genes associated with antibiotic extrusion in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 210:356-362[Medline].
11.	Nikaido, H. 1989. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 33:1831-1836[Free Full Text].
12.	Poole, K., N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J. Yamagishi, X.-Z. Li, and T. Nishino. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug resistant strain of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724[Medline].
13.	Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372[Abstract/Free Full Text].
14.	Poole, K., D. E. Heinrichs, and S. Neshat. 1993. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdin. Mol. Microbiol. 10:529-544[Medline].
15.	Rella, M., and D. Haas. 1982. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of -lactam antibiotics: mapping of chromosomal genes. Antimicrob. Agents Chemother. 22:242-249[Abstract/Free Full Text].
16.	Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
17.	Satake, S., H. Yoneyama, and T. Nakae. 1991. Role of OmpD2 and chromosomal -lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 28:199-207[Abstract/Free Full Text].
18.	Yoneyama, H., A. Ocaktan, M. Tsuda, and T. Nakae. 1997. The role of mex gene products in antibiotic extrusion in Pseudomonas aeruginosa. Biochem. Biophys. Res. Commun. 233:611-618[Medline].

---

Antimicrobial Agents and Chemotherapy, May 1999, p. 1301-1303, Vol. 43, No. 5
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

This article has been cited by other articles:

• Vettoretti, L., Plesiat, P., Muller, C., El Garch, F., Phan, G., Attree, I., Ducruix, A., Llanes, C. (2009). Efflux Unbalance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients. Antimicrob. Agents Chemother. 53: 1987-1997 [Abstract] [Full Text]  
• Hocquet, D., Berthelot, P., Roussel-Delvallez, M., Favre, R., Jeannot, K., Bajolet, O., Marty, N., Grattard, F., Mariani-Kurkdjian, P., Bingen, E., Husson, M.-O., Couetdic, G., Plesiat, P. (2007). Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections. Antimicrob. Agents Chemother. 51: 3531-3536 [Abstract] [Full Text]  
• Hocquet, D., Nordmann, P., El Garch, F., Cabanne, L., Plesiat, P. (2006). Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa.. Antimicrob. Agents Chemother. 50: 1347-1351 [Abstract] [Full Text]  
• Longbottom, C. J., Carson, C. F., Hammer, K. A., Mee, B. J., Riley, T. V. (2004). Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes. J Antimicrob Chemother 54: 386-392 [Abstract] [Full Text]  
• Yu, Y.-S., Yang, Q., Xu, X.-W., Kong, H.-S., Xu, G.-Y., Zhong, B.-Y. (2004). Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital. J Med Microbiol 53: 653-656 [Abstract] [Full Text]  
• Hocquet, D., Bertrand, X., Kohler, T., Talon, D., Plesiat, P. (2003). Genetic and Phenotypic Variations of a Resistant Pseudomonas aeruginosa Epidemic Clone. Antimicrob. Agents Chemother. 47: 1887-1894 [Abstract] [Full Text]  
• Lakaye, B., Dubus, A., Joris, B., Frere, J.-M. (2002). Method for Estimation of Low Outer Membrane Permeability to {beta}-Lactam Antibiotics. Antimicrob. Agents Chemother. 46: 2901-2907 [Abstract] [Full Text]  
• Okamoto, K., Gotoh, N., Nishino, T. (2001). Pseudomonas aeruginosa Reveals High Intrinsic Resistance to Penem Antibiotics: Penem Resistance Mechanisms and Their Interplay. Antimicrob. Agents Chemother. 45: 1964-1971 [Abstract] [Full Text]  
• Mao, W., Warren, M. S., Lee, A., Mistry, A., Lomovskaya, O. (2001). MexXY-OprM Efflux Pump Is Required for Antagonism of Aminoglycosides by Divalent Cations in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45: 2001-2007 [Abstract] [Full Text]  
• Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S., Watkins, W., Hoshino, K., Ishida, H., Lee, V. J. (2001). Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy. Antimicrob. Agents Chemother. 45: 105-116 [Abstract] [Full Text]  
• Pumbwe, L., Piddock, L. J. V. (2000). Two Efflux Systems Expressed Simultaneously in Multidrug-Resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44: 2861-2864 [Abstract] [Full Text]  
• Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., Lomovskaya, O. (2000). Interplay between Efflux Pumps May Provide Either Additive or Multiplicative Effects on Drug Resistance. J. Bacteriol. 182: 3142-3150 [Abstract] [Full Text]  
• Mazzariol, A., Cornaglia, G., Nikaido, H. (2000). Contributions of the AmpC beta -Lactamase and the AcrAB Multidrug Efflux System in Intrinsic Resistance of Escherichia coli K-12 to beta -Lactams. Antimicrob. Agents Chemother. 44: 1387-1390 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakae, T. Articles by Yoneyama, H. Search for Related Content PubMed PubMed Citation Articles by Nakae, T. Articles by Yoneyama, H.